Wednesday, May 27, 2026
RSS

Inside BCI

Brain-Computer Interface Industry News
Industry News Research Policy Opinion Market Moves
About Directory Glossary

Industry News

44 articles

Industry News

Swiss BCI startup ABILITY Neurotech wins Dutch regulatory approval to begin first chronic implantation of its fully implantable wireless BCI in ALS patients

ABILITY Neurotech, the Geneva-based Wyss Center spinout building Europe's first fully implantable wireless optical-link ECoG brain-computer interface, received Investigational Medical Device Dossier (IMDD) approval from MREC NedMec in the Netherlands on 26 May 2026 to begin the first chronic implantation study of its device in ALS patients at UMC Utrecht under the INTRECOM consortium.

May 27

Industry News

Belgian ReVision Implant closes €4M oversubscribed seed for cortical vision prosthesis, with first-in-human trial cleared for Q3 2026

Belgian neurotech ReVision Implant closed an oversubscribed €4 million seed round in May 2026 to bring manufacturing of its Occular cortical vision prosthesis in-house ahead of a first-in-human trial cleared for Q3 2026 (October surgical-window cohort), with broader early-stage trials in blind volunteers expected in summer 2027. The round follows FDA Breakthrough Device Designation granted in March 2026.

May 27

Industry News

Neuralink's surgical robot can now reach any region of the human brain, opening Parkinson's, epilepsy and depression as new target indications

Neuralink disclosed on 7 May 2026 that its next-generation R1 surgical robot can place electrode threads into virtually any region of the human brain, threading through the dura mater with real-time motion compensation and a suite of eight optical coherence tomography cameras. The scope expansion opens Parkinson's disease, refractory epilepsy, and treatment-resistant depression as new target indications beyond motor-function restoration.

May 22

Industry News

Swiss BCI startup Neurosoft closes $7.5M seed led by Skybound, the first cheque from a new EIF-anchored European deeptech fund

Neurosoft Bioelectronics closed a $7.5 million oversubscribed seed round on 20 May 2026, led by Skybound Venture Capital and joined by PL Capital, IAG Capital Partners, and Connecticut Innovations. The round brings Neurosoft's total funding past $20 million and is the inaugural investment from Skybound, a new Athens-based deeptech fund publicly launched the same week with a $38 million first close anchored by the European Investment Fund.

May 22

Industry News

UChicago Medicine joins Precision Neuroscience's clinical research network with Layer 7 sensorimotor partnership

Precision Neuroscience and UChicago Medicine announced on April 30 the launch of a clinical research partnership focused on AI-driven sensorimotor function and neuroprosthetics. The collaboration uses Precision's Layer 7 Cortical Interface, the FDA 510(k)-cleared high-density microelectrode array, and is the second material Precision institutional move of 2026, following the company's January integration with Medtronic's StealthStation surgical navigation system.

Apr 30

Industry News

Motif Neurotech's DOT wins FDA IDE for first clinical trial in treatment-resistant depression

The FDA has approved Motif Neurotech's investigational device exemption to begin a first-in-patient clinical trial of DOT, a millimeter-scale epidurally implanted wirelessly powered brain stimulator that targets the prefrontal cortex. The Rice University spinout, backed by former Neuralink president Max Hodak among others, becomes one of the first companies to attempt an implantable depression therapy at the size and patient-acceptance profile that has eluded every prior DBS-for-depression programme.

Apr 27

Industry News

ANEUVO's spinal stimulator clears the FDA

The ExaStim system — a transcutaneous spinal cord stimulator for people with chronic spinal cord injury — has received FDA 510(k) clearance, making it the first device of its kind cleared for both clinical and home use in the United States.

Apr 16

Industry News

China livestreams a brain implant: Beinao-1 goes live

Hundreds of specialists watched Beijing Tiantan Hospital implant Beinao-1, China's 128-channel semi-invasive brain-computer interface, in a young man paralysed in a scooter accident — part of a clinical ramp that is closing on Neuralink's implant count at roughly 1% of its price.

Apr 14